Evidence map›Paper›PMID 34413353›Full record

ArticleScientific reports2021

Synthesis and application of [Zr-UiO-66-PDC-SO

Amir Mohammad Naseri, Mahmoud Zarei, Saber Alizadeh, Saeed Babaee, Mohammad Ali Zolfigol, Davood Nematollahi, Jalal Arjomandi, Hu Shi

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. RSM optimization of Friedel-CraftsNanoscale advances · 2024
    Article
  11. Article
  12. Synthesis of picolinatesRSC advances · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Electro-Synthesis of Organic Compounds with Heterogeneous Catalysis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Amir Mohammad NaseriFaculty of Chemistry, Bu-Ali-Sina University, 65174-38683, Hamedan, Iran.
Mahmoud ZareiFaculty of Chemistry, Bu-Ali-Sina University, 65174-38683, Hamedan, Iran. mahmoud8103@yahoo.com.
Saber AlizadehFaculty of Chemistry, Bu-Ali-Sina University, 65174-38683, Hamedan, Iran. s.alizade66@yahoo.com.
Saeed BabaeeFaculty of Chemistry, Bu-Ali-Sina University, 65174-38683, Hamedan, Iran.
Mohammad Ali ZolfigolFaculty of Chemistry, Bu-Ali-Sina University, 65174-38683, Hamedan, Iran. zolfi@basu.ac.ir.
Davood NematollahiFaculty of Chemistry, Bu-Ali-Sina University, 65174-38683, Hamedan, Iran. nemat@basu.ac.ir.ORCID http://orcid.org/0000-0001-9638-224X
Jalal ArjomandiFaculty of Chemistry, Bu-Ali-Sina University, 65174-38683, Hamedan, Iran.
Hu ShiSchool of Chemistry and Chemical Engineering, Institute of Molecular Science, Shanxi University, Taiyuan, 030006, China.
Bu-Ali Sina University · IRShanxi University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A metal-organic framework (MOF) with sulfonic acid tags as a novel mesoporous catalyst was synthesized. The precursor of Zr-UiO-66-PDC was synthesized both via chemical and electrochemical methods. Then, zirconium-based mesoporous metal-organic framework [Zr-UiO-66-PDC-SO

Identifiers

PMID34413353
PMCPMC8377142
OpenAlexW3157468150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.